Jiaxi He

2.7k total citations
75 papers, 1.5k citations indexed

About

Jiaxi He is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Jiaxi He has authored 75 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 26 papers in Surgery and 22 papers in Oncology. Recurrent topics in Jiaxi He's work include Lung Cancer Diagnosis and Treatment (25 papers), Lung Cancer Treatments and Mutations (17 papers) and Tracheal and airway disorders (13 papers). Jiaxi He is often cited by papers focused on Lung Cancer Diagnosis and Treatment (25 papers), Lung Cancer Treatments and Mutations (17 papers) and Tracheal and airway disorders (13 papers). Jiaxi He collaborates with scholars based in China, United States and United Kingdom. Jiaxi He's co-authors include Jianxing He, Wenhua Liang, Jianfei Shen, Long Jiang, Hui Pan, Hui Pan, Xiaoshun Shi, Songhui Xu, Shuben Li and Chenglin Yang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and CHEST Journal.

In The Last Decade

Jiaxi He

69 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiaxi He China 21 842 509 317 308 223 75 1.5k
Min Fan China 23 784 0.9× 492 1.0× 537 1.7× 376 1.2× 430 1.9× 111 1.7k
Qiuhua Deng China 14 552 0.7× 389 0.8× 352 1.1× 170 0.6× 259 1.2× 38 1.1k
Paolo Muto Italy 21 664 0.8× 789 1.6× 387 1.2× 277 0.9× 207 0.9× 117 1.7k
Doris M. Rassl United Kingdom 19 1.0k 1.2× 351 0.7× 336 1.1× 263 0.9× 219 1.0× 61 1.6k
Sung‐Ja Ahn South Korea 21 619 0.7× 512 1.0× 175 0.6× 273 0.9× 311 1.4× 113 1.5k
Robert W. Mutter United States 22 418 0.5× 523 1.0× 374 1.2× 278 0.9× 483 2.2× 84 1.6k
Guoxiang Cai China 21 327 0.4× 728 1.4× 387 1.2× 399 1.3× 217 1.0× 60 1.3k
Changsong Qi China 21 408 0.5× 688 1.4× 272 0.9× 226 0.7× 195 0.9× 71 1.2k
Sook Whan Sung South Korea 31 1.5k 1.8× 510 1.0× 511 1.6× 517 1.7× 318 1.4× 87 2.4k
Shreyas Joshi United States 16 552 0.7× 376 0.7× 408 1.3× 259 0.8× 188 0.8× 91 1.2k

Countries citing papers authored by Jiaxi He

Since Specialization
Citations

This map shows the geographic impact of Jiaxi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaxi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaxi He more than expected).

Fields of papers citing papers by Jiaxi He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaxi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaxi He. The network helps show where Jiaxi He may publish in the future.

Co-authorship network of co-authors of Jiaxi He

This figure shows the co-authorship network connecting the top 25 collaborators of Jiaxi He. A scholar is included among the top collaborators of Jiaxi He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiaxi He. Jiaxi He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blakely, Collin M., Jacqulyne Robichaux, Kyung‐Yul Lee, et al.. (2025). OA02.02 Molecular Residual Disease (MRD) Analysis from NeoADAURA: Neoadjuvant Osimertinib ± Chemotherapy in Resectable EGFRm NSCLC. Journal of Thoracic Oncology. 20(10). S12–S13. 1 indexed citations
2.
He, Jiaxi, Hong Wang, Jin Li, et al.. (2024). MA15.08 Ultrasensitive Blood Test for Early Lung Cancer: Integrating Fragmentomics and Mutational Signatures in cfDNA. Journal of Thoracic Oncology. 19(10). S118–S119.
3.
Liang, Wenhua, Yun Feng, Bo Cheng, Jinghong Li, & Jiaxi He. (2023). 1263MO The impact of PET-CT and brain MRI for metastasis detection among patients with T1-stage lung cancer: Findings from a large cohort study. Annals of Oncology. 34. S732–S732.
4.
Chen, Jiawei, et al.. (2023). Impacts of additional cycles of neoadjuvant immunotherapy on surgery in non‐small‐cell lung cancer. Thoracic Cancer. 14(14). 1260–1267. 4 indexed citations
5.
Jiang, Yu, Yaokai Wen, Rui Wang, et al.. (2023). Global trends in the burden of esophageal cancer, 1990−2019: results from the Global Burden of Disease Study 2019. Journal of Thoracic Disease. 15(2). 348–364. 17 indexed citations
6.
He, Jiaxi, et al.. (2022). End-to-side anastomosis in complex tracheal resection and reconstruction: a case series study. Translational Lung Cancer Research. 11(2). 165–172. 3 indexed citations
7.
Chen, Jiawei, Hongsheng Deng, Jiaxi He, Zhufeng Wang, & Shuben Li. (2022). Impact of the interval between neoadjuvant immunochemotherapy and surgery on surgical–pathological outcomes in non-small cell lung cancer. Frontiers in Oncology. 12. 909726–909726. 7 indexed citations
8.
Wang, Rui, et al.. (2022). Electromagnetic Navigation Bronchoscopy Integrated Non-intubated Uniportal VATS in Localization and Resection of Pulmonary Nodules. Frontiers in Surgery. 9. 872496–872496. 3 indexed citations
9.
He, Jiaxi, et al.. (2020). Treatment for Patients With Early Stage Adenosquamous Lung Cancer. JTO Clinical and Research Reports. 1(2). 100021–100021. 2 indexed citations
10.
11.
12.
He, Jiaxi, Songhui Xu, Hui Pan, Shuben Li, & Jianxing He. (2020). Does size matter? —a population-based analysis of malignant pleural mesothelioma. Translational Lung Cancer Research. 9(4). 1041–1052. 10 indexed citations
13.
She, Kelin, Wei Du, Xing‐Xing Fan, et al.. (2019). SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals. Cancer Cell International. 19(1). 103–103. 58 indexed citations
14.
Wang, Q., Ying Cheng, K. Li, et al.. (2019). OA03.02 Effect of Anlotinib in Advanced Small Cell Lung Cancer Patients Previously Received Chemoradiotherapy: A Subgroup Analysis in ALTER 1202 Trial. Journal of Thoracic Oncology. 14(10). S211–S211. 3 indexed citations
15.
Shen, Jianfei, Liping Liu, Lanlan Shan, et al.. (2018). Impact of examined lymph node counts on survival of patients with stage IA non-small cell lung cancer undergoing sublobar resection. Journal of Thoracic Disease. 10(12). 6569–6577. 11 indexed citations
16.
Zhu, Zhe, et al.. (2017). Common and uncommon adverse cutaneous reactions to erlotinib: a study of 20 Chinese patients with cancer. Cutaneous and Ocular Toxicology. 37(1). 96–99. 4 indexed citations
17.
Chen, Xuewei, Liping Liu, Zhihua Guo, et al.. (2017). UGT1A1 polymorphisms with irinotecan-induced toxicities and treatment outcome in Asians with Lung Cancer: a meta-analysis. Cancer Chemotherapy and Pharmacology. 79(6). 1109–1117. 26 indexed citations
18.
Zeng, Yuan, Jiaxi He, Jianrong Zhang, et al.. (2016). Adoptive Immunotherapy in Postoperative Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. PLoS ONE. 11(9). e0162630–e0162630. 5 indexed citations
19.
He, Qihua, Mingzhe Zhang, Jianrong Zhang, et al.. (2016). Predictive value of BRCA1 expression on the efficacy of chemotherapy based on anti-microtubule agents: a pooled analysis across different malignancies and agents. Annals of Translational Medicine. 4(6). 110–110. 2 indexed citations
20.
Jiang, Long, Wenhua Liang, Jianfei Shen, et al.. (2015). The Impact of Visceral Pleural Invasion in Node-Negative Non-small Cell Lung Cancer. CHEST Journal. 148(4). 903–911. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min Fan Breakdown of academic impact, for papers by Qiuhua Deng Breakdown of academic impact, for papers by Paolo Muto Breakdown of academic impact, for papers by Doris M. Rassl Breakdown of academic impact, for papers by Sung‐Ja Ahn Breakdown of academic impact, for papers by Robert W. Mutter Breakdown of academic impact, for papers by Guoxiang Cai Breakdown of academic impact, for papers by Changsong Qi Breakdown of academic impact, for papers by Sook Whan Sung Breakdown of academic impact, for papers by Shreyas Joshi
Rankless by CCL
2026